4

Back to all posts

Press Release
AlphaLogix announces market release of AlphaFlo® canine allograft
AlphaFlo-Press-Release-Image
Equus Innovations, a manufacturer of advanced, next-generation veterinary regenerative products, in partnership with AlphaLogix, LLC (Argyle, Texas) announced today successful market release of a new canine allograft, AlphaFlo®.

You may want to read these articles

RenoVō® Case Study: Inner Ear Squamous Cell Carcinoma

RenoVō® Case Study: Inner Ear Squamous Cell Carcinoma

Case presentation: On November 3, 2022, a 13 year-old Gelding Grade Horse presented to Topgun Veterinarian Service, Rock Hill, SC, with a mass in the right inner ear. The attending veterinarian, Dr. Audrey Turbeville, performed an excisional biopsy for pathology and...